Compare VRXA & NHIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VRXA | NHIV |
|---|---|---|
| Founded | N/A | N/A |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 263.0M | 276.5M |
| IPO Year | 2025 | 2026 |
| Metric | VRXA | NHIV |
|---|---|---|
| Price | $1.98 | $10.12 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 154.8K | 5.3K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.70 | $9.96 |
| 52 Week High | $4.50 | $10.16 |
| Indicator | VRXA | NHIV |
|---|---|---|
| Relative Strength Index (RSI) | 42.65 | 62.96 |
| Support Level | $1.74 | $10.05 |
| Resistance Level | $2.00 | $10.16 |
| Average True Range (ATR) | 0.12 | 0.01 |
| MACD | 0.05 | -0.00 |
| Stochastic Oscillator | 86.00 | 63.64 |
Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.
NewHold Investment Corp IV is a blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.